JP2013533867A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013533867A5 JP2013533867A5 JP2013516930A JP2013516930A JP2013533867A5 JP 2013533867 A5 JP2013533867 A5 JP 2013533867A5 JP 2013516930 A JP2013516930 A JP 2013516930A JP 2013516930 A JP2013516930 A JP 2013516930A JP 2013533867 A5 JP2013533867 A5 JP 2013533867A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- glutamine
- dipeptide
- source
- organogel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Claims (8)
- ケロイド瘢痕を治療又は予防するための医薬を製造するための、グルタミン源の使用。
- 前記グルタミン源が、L−アラニル−L−グルタミンを含むジペプチドである請求項1記載の使用。
- 前記ジペプチドが、オルガノゲル中に懸濁されている請求項2記載の使用。
- 局所投与のための医薬組成物であって、グルタミン源を含む前記医薬組成物。
- 前記グルタミン源が、L−アラニル−L−グルタミンを含むジペプチドである請求項4記載の医薬組成物。
- 前記ジペプチドが、医薬組成物の5〜25%w/wの割合で存在する、請求項5記載の医薬組成物。
- さらに、ビヒクルを含む請求項4〜6のいずれか1項記載の医薬組成物。
- 前記ビヒクルが、オルガノゲルを含む請求項7記載の医薬組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35905310P | 2010-06-28 | 2010-06-28 | |
US61/359,053 | 2010-06-28 | ||
PCT/CA2011/050396 WO2012000113A1 (en) | 2010-06-28 | 2011-06-28 | Keloid treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013533867A JP2013533867A (ja) | 2013-08-29 |
JP2013533867A5 true JP2013533867A5 (ja) | 2014-08-14 |
Family
ID=45401271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013516930A Pending JP2013533867A (ja) | 2010-06-28 | 2011-06-28 | ケロイド治療 |
Country Status (14)
Country | Link |
---|---|
US (1) | US20140005116A1 (ja) |
EP (1) | EP2585090A4 (ja) |
JP (1) | JP2013533867A (ja) |
KR (1) | KR20130089174A (ja) |
CN (1) | CN103002903B (ja) |
AU (1) | AU2011274224A1 (ja) |
BR (1) | BR112012033349A2 (ja) |
CA (1) | CA2804413A1 (ja) |
CO (1) | CO6680624A2 (ja) |
HK (1) | HK1183626A1 (ja) |
MX (1) | MX2013000107A (ja) |
RU (1) | RU2578426C2 (ja) |
WO (1) | WO2012000113A1 (ja) |
ZA (1) | ZA201209759B (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11000545B2 (en) | 2013-03-15 | 2021-05-11 | Cda Research Group, Inc. | Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza |
US10398733B2 (en) | 2013-03-15 | 2019-09-03 | Cda Research Group, Inc. | Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body |
FR3004353B1 (fr) * | 2013-04-10 | 2015-05-15 | Fabre Pierre Dermo Cosmetique | Association synergique de l'alanine-glutamine, l'acide hyaluronique et un extrait d'avoine, et son utilisation dans une composition destinee a la cicatrisation et la reparation des lesions cutanees |
KR101800788B1 (ko) * | 2017-03-31 | 2017-11-27 | 박영오 | 켈로이드 흉터 개선용 화장료 조성물 |
US10500318B1 (en) * | 2018-07-03 | 2019-12-10 | Temple Therapeutics BV | Dosing regimens for treating hypoxia-associated tissue damage |
US11193184B2 (en) | 2019-02-22 | 2021-12-07 | Cda Research Group, Inc. | System for use in producing a metal ion suspension and process of using same |
CN114767590B (zh) * | 2022-04-20 | 2024-03-15 | 上海交通大学医学院附属第九人民医院 | 一种祛疤祛痘印美容液及其制备方法与应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5740409A (en) * | 1980-08-22 | 1982-03-06 | Mitsui Toatsu Chem Inc | Remedy for disease caused by extraordinary propagation of collagen |
US6149925A (en) * | 1998-11-05 | 2000-11-21 | Color Access, Inc. | Topical compositions for enhancing glutathione production |
WO2001014527A1 (en) * | 1999-08-23 | 2001-03-01 | Organogenesis Inc. | Skin care compositions and treatments |
JP2004532230A (ja) * | 2001-04-30 | 2004-10-21 | アラクノーバ・セラピューティックス・リミテッド | Ppar−ガンマアクチベーターを使用する瘢痕化および関連状態の処置 |
US20030105025A1 (en) * | 2001-10-31 | 2003-06-05 | Fortuna Haviv | Tri-and tetrapeptides having antiangiogenic activity |
RU2234963C2 (ru) * | 2002-09-16 | 2004-08-27 | Сибирский государственный медицинский университет | Способ лечения гипертрофических и келоидных кожных рубцов |
CN103623390A (zh) * | 2003-09-12 | 2014-03-12 | 科罗拉多州大学评议会 | 用于治疗损伤的谷氨酰胺 |
RU2275216C1 (ru) * | 2004-12-08 | 2006-04-27 | Елена Григорьевна Арий | Способ профилактики формирования патологических кожных рубцов |
DK1940439T3 (da) * | 2005-08-11 | 2011-02-14 | Univ Saskatchewan | Nedsættelse af postoperativ adhæsionsdannelse med intraperitoneal glutamin |
EP1947938A4 (en) * | 2005-11-02 | 2009-07-01 | Cpex Pharmaceuticals Inc | MACROCYCLIC FORMULATIONS FOR TRANSMEMBRANE DRUG DELIVERY |
CN100372522C (zh) * | 2005-12-02 | 2008-03-05 | 何秋莎 | 护肤品 |
CA2578647A1 (en) * | 2007-02-15 | 2008-08-15 | University Of Saskatchewan | Reducing post-operative adhesion formation with intraperitoneal glutamine |
-
2011
- 2011-06-28 JP JP2013516930A patent/JP2013533867A/ja active Pending
- 2011-06-28 KR KR1020127034180A patent/KR20130089174A/ko not_active Application Discontinuation
- 2011-06-28 EP EP11800037.1A patent/EP2585090A4/en not_active Withdrawn
- 2011-06-28 RU RU2013103507/15A patent/RU2578426C2/ru active
- 2011-06-28 BR BR112012033349A patent/BR112012033349A2/pt not_active IP Right Cessation
- 2011-06-28 MX MX2013000107A patent/MX2013000107A/es not_active Application Discontinuation
- 2011-06-28 AU AU2011274224A patent/AU2011274224A1/en not_active Abandoned
- 2011-06-28 CN CN201180031168.3A patent/CN103002903B/zh active Active
- 2011-06-28 WO PCT/CA2011/050396 patent/WO2012000113A1/en active Application Filing
- 2011-06-28 CA CA2804413A patent/CA2804413A1/en not_active Abandoned
- 2011-06-28 US US13/807,378 patent/US20140005116A1/en not_active Abandoned
-
2012
- 2012-12-21 ZA ZA2012/09759A patent/ZA201209759B/en unknown
-
2013
- 2013-01-28 CO CO13015329A patent/CO6680624A2/es unknown
- 2013-09-26 HK HK13111013.5A patent/HK1183626A1/xx unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2013533867A5 (ja) | ||
PH12017501306A1 (en) | Inhibitors of histone demethylases | |
IN2014DN09434A (ja) | ||
PH12015501404B1 (en) | Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same | |
MX2015016983A (es) | Moduladores del transporte nuclear y usos de los mismos. | |
IL232308A (en) | Compounds as modulators of atp-linked casting, pharmaceuticals containing them and their use in the preparation of drugs for the treatment of diseases and processes for their preparation | |
PH12015502539A1 (en) | Cenicriviroc compositions and methods of making and using the same | |
MX2015008627A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
BR112014014262A2 (pt) | nanopartículas; composição farmacêutica; método de administrar um ou mais agentes terapêuticos, profiláticos, e/ou diagnósticos a um paciente em necessidade dos mesmos e método de preparação das partículas. | |
EA201590161A1 (ru) | Составы этанерцепта, отличающиеся заметным уменьшением содержания частиц довидимого диапазона | |
JP2015525757A5 (ja) | ||
PH12015500746A1 (en) | Benzamides | |
EA201491281A1 (ru) | КОМПОЗИЦИЯ В ФОРМЕ СУХОГО ПОРОШКА, СОДЕРЖАЩАЯ КОРТИКОСТЕРОИД И β-АДРЕНЕРГИЧЕСКОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, ДЛЯ ВВЕДЕНИЯ ИНГАЛЯЦИЕЙ | |
MX347620B (es) | Derivados de sulfonilaminopirrolidinona, su preparacion y aplicacion terapeutica. | |
EA201591415A1 (ru) | Фармацевтические композиции, включающие многокомпонентные кристаллические частицы, подходящие для применения в ингаляционной терапии | |
MX2015008171A (es) | Formulacion que comprende agomelatina amorfa. | |
WO2014043243A3 (en) | Platinum compounds, compositions and methods for the treatment of cancer | |
BR112015004115A2 (pt) | composições farmacêuticas compreendendo flurbiprofeno | |
JP2013147480A5 (ja) | ||
JP2017517574A5 (ja) | ||
EA201590732A1 (ru) | Диспергируемая таблетка | |
WO2015060702A8 (en) | Pharmaceutical composition for controlling body mass gain comprising s-phenotropil | |
IN2014DN10683A (ja) | ||
UA97076C2 (ru) | Мазь противовоспалительная на основе сульфаниламида | |
IN2013MU01251A (ja) |